NHS Greater Glasgow and Clyde is asking patients who are currently prescribed lidocaine patches – prescribed under common names such as Ralvo or Versatis – to consider requesting a review.
The request follows a similar appeal just over a year ago and aims to reduce inappropriate use of these patches and tackle the significant costs associated with them.
Lidocaine patches provide short-term pain relief in a very small number of conditions, and their use has greatly increased in recent years – even though most of the people who receive them could use alternatives that are better for their needs.
The NHSGGC appeal last year had a significant impact, but Jane Hall, Deputy Director of Pharmacy at NHS Greater Glasgow and Clyde, has asked patients and members of the public to help NHSGGC to reduce the use of lidocaine patches further.
She said: “Lidocaine patches are an effective medicine for shingles, and they will continue to be prescribed to patients when they are effective.
“However, there are some patients who receive these patches where they may not be beneficial, and we are keen to review their use to establish ongoing need.
“Our appeal last year had a significant impact on the number of these patches prescribed, but if we can make further reductions, it will benefit our patients as well as freeing up precious resources to help in other areas.
“We would encourage anyone who is currently prescribed these patches to ask for a review by the GP practice pharmacy team, so that you can ensure that your prescription is right for you.
“We would also ask people to speak to a friend or loved one who uses these patches and encourage them to seek a review of their prescription.”
Lidocaine patches are only indicated for the short-term treatment of nerve pain following shingles. They are not always suitable for long-term use or for other types of pain, such as back pain or hip pain, as they are considered ineffective for these purposes.
To find out more about taking control of your treatments, go to NHS Inform.